International Cross-Cultural Field Validation of an EORTC Questionnaire Module for the Assessment of Cancer Related Fatigue (EORTC QLQ FA13) - Phase IV

International Cross-Cultural Field Validation of an EORTC Questionnaire Module for the Assessment of Cancer Related Fatigue (EORTC QLQ FA13) - Phase IV - EORTC QLQ-FA13

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003091

Enrollment

512

Registered

2011-06-28

Start date

2011-07-04

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer related fatigue

Interventions

Group 1: Cancer patients with first-line treatment with curative intension. Schedule of the assessments according to the study protocol: before (T1), during (T2) and after (T3) the treatment. Used ins

T2: EORTC QLQ-C30, EORTC QLQ-FA13

T3: EORTC QLQ-C30, EORTC QLQ-FA13. Group 2: Cancer patients with second-line treatment with palliative intension. Schedule of the assessments according to the study protocol: before (T1), during (T2)

T3: EORTC QLQ-C30, EORTC QLQ-FA13. Group 3: Cancer patients off treatment for at least 12 but no more than 18 months and no evidence of cancer disease or recurrence. Schedule of the assessments: two t

T2: EORTC QLQ-C30, EORTC QLQ-FA13. Group 4: Cancer patients off treatment for more than 36 but no more than 72 months (survivors) and no evidence of cancer disease or recurrence. Schedule of the asses

T2: EORTC QLQ-C30, EORTC QLQ-FA13.

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Age 18 years or older (no upper limit); Histologically confirmed cancer

Exclusion criteria

Exclusion criteria: Patients undergoing allogeneic HSCT; Participation in other quality of life studies; Disability to understand the language of the questionnaire. Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.

Design outcomes

Primary

Measure	Time frame
International Cross-Cultural Field Validation of an EORTC Questionnaire Module for the Assessment of Cancer Related Fatigue (EORTC QLQ FA13)	—

Countries

Austria, France, Germany, Italy, Spain, Sweden, United Kingdom

Contacts

Public ContactJoachim Weis

Klinik für Tumorbiologie

weis@tumorbio.uni-freiburg.de+49 761 206 2220

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026